Home › NDC Lookup › RxCUI directory › RxCUI 422410

Midazolam 2 MG/ML Oral Solution — RxCUI 422410

Name: Midazolam 2 MG/ML Oral Solution (RxCUI 422410)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 422410 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI422410

Official nameMidazolam 2 MG/ML Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asmidazolam 10 MG per 5 ML Oral Solution; midazolam 10 MG in 5 mL Oral Solution; midazolam (as midazolam hydrochloride) 10 MG per 5 ML Syrup; midazolam (as midazolam hydrochloride) 2 MG/ML Syrup

FDA products mapped6

Package NDCs mapped7

Reported Medicaid activity (SDUD)5,415 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Midazolam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

That's actually one of the intentional effects of midazolam — it reliably blocks the brain's ability to form new memories for several hours after a dose. So even if you're awake an...
Why will I not remember what happened during my procedure?
You should not drive or operate any machinery until the full effects have worn off — and that can take up to 6 hours or sometimes longer. Plan to have someone drive you home. Even...
Is it safe to go home right after receiving midazolam?

📖 Read our full Midazolam guide →

🕸️ Concept Web — How Midazolam 2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Midazolam 2 MG/ML Oral Solution RxCUI 422410 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Midazolam 6960 IN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Midazolam Oral Solution 446503 SCDF
- Midazolam Oral Liquid Product 1164716 SCDG
- Midazolam Oral Product 1164717 SCDG
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- Oral Product 1151131 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Midazolam 2 MG/ML 330380 SCDC

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Midazolam 2 MG/ML SCDC · 330380
Midazolam Oral Solution SCDF · 446503
Midazolam Oral Liquid Product SCDG · 1164716
Midazolam Oral Product SCDG · 1164717

📦 FDA Products & Package NDCs

6 products · 7 package NDCs

7 package NDCs map to RxCUI 422410 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00054-3566-99	118 mL in 1 BOTTLE, GLASS (0054-3566-99)	Midazolam Hydrochloride	Hikma Pharmaceuticals USA Inc.	2002-04-30
00574-0150-04	1 BOTTLE, GLASS in 1 CARTON (0574-0150-04) / 118 mL in 1 BO...	Midazolam Hydrochloride	Padagis US LLC	2005-05-02
60687-0576-10	3 TRAY in 1 CASE (60687-576-10) / 10 CUP, UNIT-DOSE in 1 TR...	Midazolam Hydrochloride	American Health Packaging	2021-06-15
60687-0576-86	3 TRAY in 1 CASE (60687-576-86) / 10 CUP, UNIT-DOSE in 1 TR...	Midazolam Hydrochloride	American Health Packaging	2021-06-15
68094-0762-62	3 TRAY in 1 CASE (68094-762-62) / 10 CUP, UNIT-DOSE in 1 TR...	Midazolam Hydrochloride	Precision Dose Inc.	2015-05-26
68094-0764-62	3 TRAY in 1 CASE (68094-764-62) / 10 CUP, UNIT-DOSE in 1 TR...	Midazolam Hydrochloride	Precision Dose Inc.	2015-05-26
72162-1109-02	1 BOTTLE, GLASS in 1 CARTON (72162-1109-2) / 118 mL in 1 BO...	Midazolam Hydrochloride	Bryant Ranch Prepack	2023-10-25

Observed labelers: American Health Packaging (2) · Precision Dose Inc. (2) · Bryant Ranch Prepack (1) · Hikma Pharmaceuticals USA Inc. (1) · Padagis US LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$0.6871

Range $0.6871–$0.6871 · middle 50% $0.6871–$0.6871 · 2 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.